Literature DB >> 31650302

Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.

Mitsuro Kanda1, Masahiko Koike2, Dai Shimizu2, Chie Tanaka2, Daisuke Kobayashi2, Norifumi Hattori2, Masamichi Hayashi2, Kenji Omae3, Suguru Yamada2, Goro Nakayama2, Yasuhiro Kodera2.   

Abstract

BACKGROUND: Squamous cell carcinoma antigen (SCC-Ag) and carcinoembryonic antigen (CEA) are widely used in clinical practice to predict the prognosis of patients with esophageal squamous cell carcinoma (ESCC). However, their predictive values for prognosis are controversial. This study determined optimal cutoff values of serum SCC-Ag and CEA concentrations for predicting postoperative recurrence of ESCC, which enabled selection of high-risk patients.
METHODS: The study retrospectively analyzed 427 patients who underwent curative resection for ESCC. The optimal cutoff values of preoperative SCC-Ag and CEA concentrations for predicting postoperative recurrence were determined using combined analysis of hazard ratios and sensitivities for recurrence. Using the optimal cutoff value, the study evaluated survival, recurrence patterns, and temporal changes in marker concentrations.
RESULTS: The preoperative SCC-Ag concentration of 1.1 ng/ml was the optimal cutoff value for predicting postoperative recurrence, whereas precise cutoff values could not be determined for preoperative CEA concentrations. High preoperative SCC-Ag concentrations (> 1.1 ng/ml), which were significantly associated with more aggressive tumor phenotypes and shorter disease-free survival, were identified as an independent prognostic factor in the multivariable analysis. High preoperative SCC-Ag concentrations were significantly associated with greater prevalence of lung/pleura and local recurrences. Normalization of serum SCC-Ag concentrations after neoadjuvant treatment or esophagectomy was not associated with a decreased risk of postoperative recurrence.
CONCLUSIONS: The optimal cutoff value of preoperative SCC-Ag concentrations that predicted recurrence of ESCC was 1.1 ng/ml, illuminating the utility of serum SCC-Ag concentrations as an easily measurable tool for selecting a perioperative management strategy.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31650302     DOI: 10.1245/s10434-019-07977-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  4 in total

1.  The prognosis role of AJCC/UICC 8th edition staging system in gastric cancer, a retrospective analysis.

Authors:  Jiu-Yang Liu; Chun-Wei Peng; Xiao-Jun Yang; Chao-Qun Huang; Yan Li
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

2.  The Preoperative Prognostic Nutritional Index Predicts Short-Term and Long-Term Outcomes of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-Institution Dataset.

Authors:  Masahiro Sasahara; Mitsuro Kanda; Seiji Ito; Yoshinari Mochizuki; Hitoshi Teramoto; Kiyoshi Ishigure; Toshifumi Murai; Takahiro Asada; Akiharu Ishiyama; Hidenobu Matsushita; Chie Tanaka; Daisuke Kobayashi; Michitaka Fujiwara; Kenta Murotani; Yasuhiro Kodera
Journal:  Dig Surg       Date:  2019-03-06       Impact factor: 2.588

3.  Serum markers as predictors of esophageal squamous dysplasia and early cancer.

Authors:  Wen Chen; Christian C Abnet; Wen-Qiang Wei; Mark J Roth; Ning Lu; Philip R Taylor; Qin-Jing Pan; Xian-Mao Luo; Sanford M Dawsey; You-Lin Qiao
Journal:  Anticancer Res       Date:  2004 Sep-Oct       Impact factor: 2.480

4.  Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study.

Authors:  Mitsuro Kanda; Yun-Suhk Suh; Do Joong Park; Chie Tanaka; Sang-Hoon Ahn; Seong-Ho Kong; Hyuk-Joon Lee; Daisuke Kobayashi; Michitaka Fujiwara; Hideaki Shimada; BeLong Cho; Kenta Murotani; Hyung-Ho Kim; Han-Kwang Yang; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2019-08-03       Impact factor: 7.370

  4 in total
  3 in total

1.  Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma.

Authors:  Mengyang Ju; Xiaolin Ge; Xiaoke Di; Yumeng Zhang; Liang Liang; Yujing Shi
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

2.  Prognostic Significance of the Combination of Fibrinogen and Tumor Marker Index in Esophageal Squamous Cell Carcinoma Patients.

Authors:  Yufeng Qiao; Mingquan Ma; Hongdian Zhang; Zhentao Yu; Peng Tang
Journal:  Onco Targets Ther       Date:  2021-02-17       Impact factor: 4.147

3.  Surveillance of Esophageal Cancer in the Republic of Uzbekistan from 2000 to 2018.

Authors:  Abror Yusupbekov; Mitsuro Kanda; Bekhzod Usmanov; Otabek Tuychiev; Sayfiddin Baymakov; Junichi Sakamoto; Akhrorbek Yusupbekov
Journal:  Asian Pac J Cancer Prev       Date:  2020-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.